In an independent study, a novel TFEB activator improved the glucose tolerance and metabolic profile in genetically induced diabetes (ob/ob) and in diet-induced obesity mouse models [48]. This evidence concerns the gene TFEB and obesity due to melanocortin 4 receptor deficiency.